MEIRAGTX
MeiraGTx is committed to the development and commercialization of innovative gene therapy products to transform the lives of patients suffering from acquired and inherited disorders. We are a vertically integrated, clinical stage gene therapy company with five ongoing clinical programs and a broad pipeline of preclinical and research programs. We have core capabilities in viral vector design and optimization and gene therapy manufacturing as well as a potentially transformative gene regulation ... technology. Led by an experienced management team, we have taken a portfolio approach by licensing, acquiring and developing technologies that give us depth across both product candidates and indications. Though initially focusing on the eye, salivary gland and central nervous system, we intend to expand our focus in the future to develop additional gene therapy treatments for patients suffering from a range of serious diseases.
MEIRAGTX
Industry:
Biotechnology Health Care Therapeutics
Founded:
2015-03-20
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.meiragtx.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
82.66 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Harpoon Therapeutics
Harpoon Therapeutics is a clinical-stage immunotherapy company developing novel T cell engagers (TriTACs) for the treatment of cancer.
Milestone Pharmaceuticals
Milestone Pharmaceuticals is a drug development company developing small molecule therapeutics for the treatment of cardiovascular diseases.
Voyager Therapeutics
Voyager Therapeutics is a gene therapy company developing treatments for fatal and debilitating diseases of the central nervous system
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2018-10-05 | Vector Neurosciences | Vector Neurosciences acquired by MeiraGTx | N/A |
Investors List
Perceptive Advisors
Perceptive Advisors investment in Post-IPO Debt - MeiraGTx
Essex Bio-Technology
Essex Bio-Technology investment in Series B - MeiraGTx
UCL Technology Fund
UCL Technology Fund investment in Venture Round - MeiraGTx
AlbionVC
AlbionVC investment in Venture Round - MeiraGTx
Key Employee Changes
| Date | New article |
|---|---|
| 2020-08-05 | MeiraGTx Names Immunovant’s Zeldin as Its Chief Medical Officer |
Official Site Inspections
http://www.meiragtx.com Semrush global rank: 1.04 M Semrush visits lastest month: 32.44 K
- Host name: 153.95.193.35.bc.googleusercontent.com
- IP address: 35.193.95.153
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
